Ryoko Yoshikawa

1.1k citations

19 papers · 972 indexed · h-index 15

Cellular and Molecular Neuroscience top 5%
Molecular Biology
Organic Chemistry top 10%
Pharmacology top 10%
Biological Psychiatry top 5%

Co-authors: Shigeyuki Chaki Atsuro Nakazato Shigeru Okuyama Taketoshi Okubo Kazunari Sakagami Akito Yasuhara Shigetada Nakanishi Yoshiko Suzuki
Topics: Neuroscience and Neuropharmacology Research (12 papers)Receptor Mechanisms and Signaling (12 papers)Neurotransmitter Receptor Influence on Behavior (5 papers)
Cited by: Biological Psychiatry Cellular and Molecular Neuroscience Pharmaceutical Science
Journals: Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics Life Sciences
Partner nations: Japan

In The Last Decade

Ryoko Yoshikawa

19 papers receiving 957 citations

Peers

Countries citing papers authored by Ryoko Yoshikawa

Since Specialization

Citations

This map shows the geographic impact of Ryoko Yoshikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryoko Yoshikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryoko Yoshikawa more than expected).

Fields of papers citing papers by Ryoko Yoshikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryoko Yoshikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryoko Yoshikawa. The network helps show where Ryoko Yoshikawa may publish in the future.

Co-authorship network of co-authors of Ryoko Yoshikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ryoko Yoshikawa. A scholar is included among the top collaborators of Ryoko Yoshikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryoko Yoshikawa. Ryoko Yoshikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression 2015 ·Molecular Cancer ·Tetsuo Hirano,Ryoko Yoshikawa,Hironori Harada,Yuka Harada,Atsuhiko Ishida,Takeshi Yamazaki	83
2	Synthesis, in vitro pharmacology, and pharmacokinetic profiles of 2-[1-amino-1-carboxy-2-(9H-xanthen-9-yl)-ethyl]-1-fluorocyclopropanecarboxylic acid and its 6-heptyl ester, a potent mGluR2 antagonist 2008 ·Bioorganic & Medicinal Chemistry ·Kazunari Sakagami,Akito Yasuhara,Shigeyuki Chaki,Ryoko Yoshikawa,(unknown),Akio Saito,Takeo Taguchi,Atsuro Nakazato	15
3	Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): A potent and orally active group II mGluR antagonist with antidepressant-like potential 2006 ·Bioorganic & Medicinal Chemistry ·Akito Yasuhara,Masato Nakamura,Kazunari Sakagami,Toshiharu Shimazaki,Ryoko Yoshikawa,Shigeyuki Chaki,Hiroshi Ohta,Atsuro Nakazato	39
4	Synthesis, in vitro pharmacology, and structure–activity relationships of 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as mGluR2 antagonists 2006 ·Bioorganic & Medicinal Chemistry ·Akito Yasuhara,Kazunari Sakagami,Ryoko Yoshikawa,Shigeyuki Chaki,Masato Nakamura,Atsuro Nakazato	12
5	Group II metabotropic glutamate receptor-mediated regulation of dopamine release from slices of rat nucleus accumbens 2006 ·Neuroscience Letters ·Shigeyuki Chaki,Ryoko Yoshikawa,Shigeru Okuyama	20
6	Thapsigargin-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in PC12 cells 2006 ·Neuroscience Letters ·Tsuneo Takadera,Ryoko Yoshikawa,Takao Ohyashiki	15
7	Design, synthesis, and structure–activity relationships of novel tetracyclic compounds as peripheral benzodiazepine receptor ligands 2004 ·Bioorganic & Medicinal Chemistry ·Taketoshi Okubo,Ryoko Yoshikawa,Shigeyuki Chaki,Shigeru Okuyama,Atsuro Nakazato	47
8	Synthesis, in Vitro Pharmacology, Structure−Activity Relationships, and Pharmacokinetics of 3-Alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent and Selective Group II Metabotropic Glutamate Receptor Antagonists 2004 ·Journal of Medicinal Chemistry ·Atsuro Nakazato,Kazunari Sakagami,Akito Yasuhara,Hiroshi Ohta,Ryoko Yoshikawa,Manabu Itoh,Masato Nakamura,Shigeyuki Chaki	47
9	Design, synthesis and structure–affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands 2003 ·Bioorganic & Medicinal Chemistry ·Taketoshi Okubo,Ryoko Yoshikawa,Shigeyuki Chaki,Shigeru Okuyama,Atsuro Nakazato	146
10	MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity 2003 ·Neuropharmacology ·Shigeyuki Chaki,Ryoko Yoshikawa,(unknown),Toshiharu Shimazaki,(unknown),Naoya Kawashima,Takao Yoshimizu,Akito Yasuhara,Kazunari Sakagami,Shigeru Okuyama,Shigetada Nakanishi,Atsuro Nakazato	221
11	In vitro and in vivo pharmacological profile of 5-{2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl}-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic 2002 ·Life Sciences ·Takeo Funakoshi,Shigeyuki Chaki,Naoya Kawashima,Yoshiko Suzuki,Ryoko Yoshikawa,Toshihito Kumagai,Atsuro Nakazato,Kazuya Kameo,Makoto Goto,Shigeru Okuyama	15
12	Synthesis, SARs, and Pharmacological Characterization of 2-Amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent, Selective, and Orally Active Group II Metabotropic Glutamate Receptor Agonists 2000 ·Journal of Medicinal Chemistry ·Atsuro Nakazato,Toshihito Kumagai,Kazunari Sakagami,Ryoko Yoshikawa,Yoshiko Suzuki,Shigeyuki Chaki,Hisanaka Ito,Takeo Taguchi,Shigetada Nakanishi,Shigeru Okuyama	98
13	Binding characteristics of DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors 1999 ·European Journal of Pharmacology ·Shigeyuki Chaki,Takeo Funakoshi,Ryoko Yoshikawa,Shigeru Okuyama,Taketoshi Okubo,Atsuro Nakazato,(unknown),Kazuyuki Tomisawa	69
14	A selective dopamine D4 receptor antagonist, NRA0160: A preclinical neuropharmacological profile 1999 ·Life Sciences ·Shigeru Okuyama,Naoya Kawashima,(unknown),Ryoko Yoshikawa,Takeo Funakoshi,Shinichi Ogawa,Yoshiko Suzuki,Yoko Ikeda,Toshihito Kumagai,Atsuro Nakazato,(unknown),Kazuyuki Tomisawa	24
15	Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106 1999 ·Life Sciences ·(unknown),Shigeyuki Chaki,Ryoko Yoshikawa,Shinichi Ogawa,Yoshiko Suzuki,Taketoshi Okubo,Atsuro Nakazato,(unknown),Kazuyuki Tomisawa	81
16	In vivo receptor occupancy of NRA0045, a putative atypical antipsychotic, in rats 1999 ·Neuropharmacology ·Shigeyuki Chaki,Takeo Funakoshi,Ryoko Yoshikawa,Shigeru Okuyama,Toshihito Kumagai,Atsuro Nakazato,(unknown),Kazuyuki Tomisawa	11
17	In vivo receptor occupancy of an atypical antipsychotic, NRA0045, in rats 1998 ·The Japanese Journal of Pharmacology ·Shigeyuki Chaki,Takeo Funakoshi,Ryoko Yoshikawa,Shigeru Okuyama,Yoko Ikeda,Toshihito Kumagai,Atsuro Nakazato,(unknown),Masanori Yoshida,Kazuyuki Tomisawa	1
18	In Vitro and In Vivo Characterization of the Dopamine D4 Receptor, Serotonin 5-HT2AReceptor and Alpha-1 Adrenoceptor Antagonist (R)-(+)-2-Amino-4-(4-Fluorophenyl)- 5-[1-[4-(4-Fluorophenyl)-4-Oxobutyl]Pyrrolidin-3-yl]Thiazole (NRA0045) 1997 ·Journal of Pharmacology and Experimental Therapeutics ·Shigeru Okuyama,(unknown),Ryoko Yoshikawa,Yoshiko Suzuki,Shinichi Ogawa,Yasuko Imagawa,Naoya Kawashima,Yoko Ikeda,Toshihito Kumagai,Atsuro Nakazato,(unknown),Kazuyuki Tomisawa	25
19	Neuroprotective effect of 4′-(4-methylphenyl)-2,2′:6′,2-terpyridine trihydrochloride, a novel inducer of nerve growth factor 1996 ·Life Sciences ·Kyoko Yamamoto,Ryoko Yoshikawa,Shigeru Okuyama,Yuki Takahashi,Yasuko Karasawa,(unknown),(unknown),Hiroaki Araki,Kenji Hanabusa,Hirofusa Shirai,Kazuyuki Tomisawa	3

About Ryoko Yoshikawa

Ryoko Yoshikawa is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology, having authored 19 papers that have together received 972 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (12 papers), Receptor Mechanisms and Signaling (12 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). The work is most often cited by research in Biological Psychiatry (120 citations), Cellular and Molecular Neuroscience (481 citations) and Pharmaceutical Science (67 citations). Ryoko Yoshikawa has collaborated with scholars based in Japan. Frequent co-authors include Shigeyuki Chaki, Atsuro Nakazato, Shigeru Okuyama, Taketoshi Okubo, Kazunari Sakagami, Akito Yasuhara, Shigetada Nakanishi, Yoshiko Suzuki, Naoya Kawashima and Toshiharu Shimazaki. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact